XASE
NSRX
Oct 08, Last price
3.63USD
1D
-3.84%
1Q
23.89%
IPO
-54.91%
Name
Nasus Pharma Ltd
Chart & performance
P/E
—
P/S
—
EPS
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
Net income
CFO
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Key people
Dan Teleman
Chief Executive Officer · since 2025
Udi Gilboa
Co-Founder, Executive Chairman of the Board of Director · since 2019
Executive Vice President, Chief Financial Officer · since 2025
Oren Elmaliach
Director of Finance · since 2019
Galia Kryaz
Director of CMC and Product Development · since 2019
Dalia Megiddo
Co-Founder, Director, Chief Development Officer and Chief Medical Officer · since 2019
Ronnie Hershman
Independent Director · since 2020
Isaac Israel
Independent Director Nominee
Sharon Shacham
Independent Director Nominee
Independent Director Nominee
Valuation
No data to show